Discuss a project

Analytical Method Development

Upperton offers extensive analytical method and validation services as part of our development services as well as stand-alone analytical testing services for projects throughout each stage of the drug life cycle from pre-clinical through to late phase. Our analytical scientists develop and validate methods that support product quality, stability, regulatory compliance and clinical progression.

Analytical Method development

Analytical Research and Development

Our team have access to a wide range of techniques to support your project.

Successful development programmes begin with a thorough understanding of the physio-chemical characteristics of the API. Additionally, it is important to understand any potential stability or excipient incompatibility challenges.

Using a range of techniques including DSC, TGA, XRPD, Microscopy, FTIR, Particle sizing etc, we gain a fundamental understanding and insight into the behaviours of your API to support the development activities required for first in human studies and product development.

Analytical & Characterisation Capabilities

Traditional Methods

  • HPLC
  • Dissolution
  • Spectrophotometric Analysis
  • FTIR
  • Karl Fischer

Physical Characterisation

  • Laser Particle Sizing
  • Electron Microscopy
  • Differential Scanning Calorimetry
  • X-Ray Diffraction
  • Dynamic Vapour Sorption
  • Powder Rheology

Dosage Form Testing

  • NGI Powder Deposition (Pulmonary)
  • AIVI Deposition (Nasal)
  • Nasal Spray Characterisation
  • Dissolution Testing (Biorelevant & Traditional)

Biologics

  • Gel Electrophoresis
  • Western Blotting
  • ELISA
  • Spectrophotometric Analysis
  • Sub-Visible Particulates

YOUR STRATEGIC CDMO PARTNER

Partner with Upperton

We provide fully integrated CDMO services across every stage of the drug product lifecycle.

Analytical FAQs

Reliable analytical methods are essential for generating accurate data, understanding product characteristics, ensuring quality and supporting regulatory compliance. Early investment in robust method development can reduce development risks, prevent delays and facilitate smoother progression through clinical and commercial stages.

We recognise that every molecule and development programme is unique. Our team develops customised analytical approaches based on your product attributes, regulatory requirements, development phase and long-term commercial objectives.

Speak to us about our analytical method development services

This field is for validation purposes and should be left unchanged.